Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

B-Cell Targeted Desensitization With Carfilzomib for Preformed Anti-HLA Antibodies in Patients Awaiting Kidney Transplantation

NCT02442648 is registered in ClinicalTrials.gov with E. Steve Woodle as lead sponsor.

NCT NCT02442648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02442648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
B-Cell Targeted Desensitization With Carfilzomib for Preformed Anti-HLA Antibodies in Patients Awaiting Kidney Transplantation
Lead sponsor
E. Steve Woodle
Phase
Phase 1
Overall status
Unknown status
Start date
December 31, 2014
Completion date
September 30, 2021
Enrollment
32 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

transplants and implants